Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Increased teniposide clearance with concomitant anticonvulsant therapyD K Baker, M V Relling, C H Pui, et al.
Clinical Pharmacology and Therapeutics|June 1, 1987
Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapyM V Relling, W R Crom, J A Pieper, et al.
The New England Journal of Medicine|February 19, 1998
Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemiaW E Evans, M V Relling, J H Rodman, et al.
Human Molecular Genetics|February 5, 1999
Polymorphism of the thiopurine S-methyltransferase gene in African-AmericansY Y Hon, M Y Fessing, C H Pui, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemiaM E van de Poll, M V Relling, E G Schuetz, et al.
Leukemia|July 30, 2003
Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patientsB Wang, M V Relling, M C Storm, et al.
Leukemia|April 7, 1998
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemiaM V Relling, Y Yanishevski, J Nemec, et al.
Leukemia|January 8, 2010
ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidenceW Yang, L R Treviño, J J Yang, et al.
Pediatric Clinics of North America|October 1, 1989
Clinical pharmacology of cancer chemotherapy in childrenW E Evans, W P Petros, M V Relling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Patient characteristics associated with high-risk methotrexate concentrations and toxicityM V Relling, D Fairclough, D Ayers, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Increased teniposide clearance with concomitant anticonvulsant therapyD K Baker, M V Relling, C H Pui, et al.
Clinical Pharmacology and Therapeutics|June 1, 1987
Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapyM V Relling, W R Crom, J A Pieper, et al.
The New England Journal of Medicine|February 19, 1998
Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemiaW E Evans, M V Relling, J H Rodman, et al.
Human Molecular Genetics|February 5, 1999
Polymorphism of the thiopurine S-methyltransferase gene in African-AmericansY Y Hon, M Y Fessing, C H Pui, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemiaM E van de Poll, M V Relling, E G Schuetz, et al.
Leukemia|July 30, 2003
Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patientsB Wang, M V Relling, M C Storm, et al.
Leukemia|April 7, 1998
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemiaM V Relling, Y Yanishevski, J Nemec, et al.
Leukemia|January 8, 2010
ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidenceW Yang, L R Treviño, J J Yang, et al.
Pediatric Clinics of North America|October 1, 1989
Clinical pharmacology of cancer chemotherapy in childrenW E Evans, W P Petros, M V Relling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Patient characteristics associated with high-risk methotrexate concentrations and toxicityM V Relling, D Fairclough, D Ayers, et al.
Pageof 18